Dysnatremia in COVID-19 Patients-An Analysis of the COLOS Study.
Anna KrólickaKrzysztof LetachowiczBarbara AdamikAdrian DoroszkoKrzysztof KaliszewskiKatarzyna Kiliś-PstrusińskaKrzysztof KujawaAgnieszka Matera-WitkiewiczMarcin MadziarskiMichał PomorskiMarcin ProtasiewiczJanusz SokołowskiMałgorzata TrochaEwa Anita JankowskaKatarzyna MadziarskaPublished in: Journal of clinical medicine (2023)
Both hypo- and hypernatremia are strong predictors of mortality and disease severity in COVID-19 patients. Extraordinary care should be taken when dealing with hypernatremic, COVID-positive patients, as this group exhibits the highest mortality rates.
Keyphrases
- sars cov
- end stage renal disease
- coronavirus disease
- cardiovascular events
- healthcare
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- palliative care
- quality improvement
- respiratory syndrome coronavirus
- type diabetes
- cardiovascular disease
- patient reported
- health insurance